Latuda (lurasidone), a New Atypical Antipsychotic Agent for Adults with Schizophrenia, Now Available in the UK, Offers a Combination of Efficacy with Tolerability
"Corporate profile" An English version and a Japanese version are updated.
Posted Conference Call for First Quarter Financial Results for FY2014 [Webcast]
Presentation Material (First Quarter Financial Results for FY2014)
Supplementary Financial Data for the First Quarter of the Year Ending March 31, 2015
Summary of Consolidated Financial Results for the First Quarter of the Year Ending March 31, 2015 (Unaudited)
A Message from the President
Board of Directors and Executive Officers